Dashboard
Manage Tickers

CLPT ClearPoint Neuro, Inc.


$ 25.41 $ 0.60 (2.42 %)    

Friday, 17-Oct-2025 15:59:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.00 $ 6.40 (1.07 %)
DIA $ 461.73 $ 2.36 (0.51 %)
SPY $ 664.30 $ 4.83 (0.73 %)
TLT $ 91.18 $ -0.05 (-0.05 %)
GLD $ 389.19 $ -8.00 (-2.01 %)
$ na
$ 25.00
$ 25.40 x 1
$ 25.50 x 1
$ 23.50 - $ 25.85
$ 9.76 - $ 30.10
708,472
na
718.65M
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

clearpoint-neuro-shares-are-trading-higher-wednesday-whats-going-on
ClearPoint Neuro Shares Are Trading Higher...
10/08/2025 18:27:39

ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II c...

clearpoint-neuro-reports-phase-i-ii-results-for-prism-laser-system-in-glioblastoma-study-improved-survival-compared-to-matched-open-surgery-controls-safe-feasible-and-reproducible-workflow-median-ablation-time-65-minutes
ClearPoint Neuro Reports Phase I-II Result...
10/07/2025 20:17:44

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

clearpoint-neuro-secures-regulatory-approvals-in-canada-hong-kong-and-taiwan-expanding-clinical-access-to-34-countries
ClearPoint Neuro Secures Regulatory Approv...
10/06/2025 20:13:14

The clearly established history across global regulatory bodies is expected to de-risk BioPharma partners' pathways towards...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/03/2025 12:08:34

clearpoint-neuro-unveils-robotic-neuro-navigation-system-to-advance-cell-and-gene-therapy-procedures
ClearPoint Neuro Unveils Robotic Neuro-Nav...
10/01/2025 20:10:23

New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene TherapySOLANA BEACH, CALIFOR...

clearpoint-neuro-announces-the-development-and-demonstration-of-its-robotic-neuro-navigation-system
ClearPoint Neuro Announces The Development...
10/01/2025 20:09:32

why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket
Why PepGen Shares Are Trading Higher By 11...
09/25/2025 10:11:08

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/24/2025 17:06:12

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/24/2025 12:10:28

clearpoint-neuro-secures-fda-clearance-for-15t-mri-use-expanding-reach-for-prism-neuro-laser-system
ClearPoint Neuro Secures FDA Clearance For...
09/04/2025 20:10:28

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

clearpoint-neuro-affirms-fy2025-sales-guidance-of-36000m-41000m-vs-38150m-est
ClearPoint Neuro Affirms FY2025 Sales Guid...
08/12/2025 20:06:31

ClearPoint Neuro (NASDAQ:CLPT) affirms FY2025 sales outlook from $36.000 million-$41.000 million to $36.000 million-$41.000 mil...

clearpoint-neuro-q2-eps-021-misses-018-estimate-sales-9215m-beat-9200m-estimate
ClearPoint Neuro Q2 EPS $(0.21) Misses $(0...
08/12/2025 20:06:03

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

clearpoint-neuro-achieves-key-milestones-with-first-us-commercial-gene-therapy-infusions-using-smartflow-device-for-aadc-deficiency
ClearPoint Neuro Achieves Key Milestones W...
08/04/2025 20:37:14

ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering pre...

stifel-maintains-buy-on-clearpoint-neuro-raises-price-target-to-9
Stifel Maintains Buy on ClearPoint Neuro, ...
08/01/2025 14:45:26

Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $8 to $9.

on-june-16-2025-clearpoint-neuro-entered-into-a-lease-agreement-with--bre-bmr-scd-to-expand-into-approximately-30171-square-feet-within-a-life-science-building-located-in-san-diego-california
On June 16, 2025, Clearpoint Neuro Entered...
06/17/2025 20:19:56

-SEC Filing

clearpoint-neuro-reports-q1-earnings-revenue-beat-eps-miss-company-affirms-fy25-guidance
ClearPoint Neuro Reports Q1 Earnings: Reve...
05/13/2025 21:30:26

ClearPoint Neuro announces Q1 earnings, beating revenue estimates but missing earnings estimates. Company affirms full-year sal...

clearpoint-neuro-affirms-fy2025-sales-guidance-of-3600m-4100m-vs-3823m-est
ClearPoint Neuro Affirms FY2025 Sales Guid...
05/13/2025 20:37:06

ClearPoint Neuro (NASDAQ:CLPT) affirms FY2025 sales outlook from $36.00 million-$41.00 million to $36.00 million-$41.00 million...

clearpoint-neuro-q1-eps-022-misses-016-estimate-sales-848m-beat-820m-estimate
ClearPoint Neuro Q1 EPS $(0.22) Misses $(0...
05/13/2025 20:36:34

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION